ANTIBIOTIC PROPHYLAXIS IN SURGICAL SITE INFECTION PREVENTION: A PROSPECTIVE OBSERVATIONAL STUDY OF CLEAN AND CLEAN-CONTAMINATED CASES
Abstract
Background: Surgical Site Infections (SSIs) remain a major cause of postoperative morbidity, especially in clean and clean-contaminated surgeries. Optimal antibiotic prophylaxis is essential to prevent SSIs and reduce hospital burden. Objective: To compare the effectiveness of preoperative prophylactic antibiotics versus postoperative therapeutic antibiotics in preventing SSIs and to evaluate the influence of risk factors, timing, and antibiotic choice. Methods: A prospective observational study was conducted for six months in the Department of General Surgery, Malla Reddy Hospital. A total of 250 patients were allocated into two equal groups based on antibiotic strategy. • Group A: Received a single dose of IV pre-operative Antibiotic (ceftriaxone) 30–60 minutes before surgical incision. • Group B: Received only postoperative antibiotic therapy (cefotaxime/ceftriaxone/ fluroquinolones) for 2–3 days without pre-operative prophylaxis. Demographics, comorbidities, surgery type, antibiotic timing, and SSI occurrence were assessed. Statistical tests included Chi-square, ANOVA, and logistic regression. Results: Group A demonstrated a significantly lower SSI rate (23.2%) compared to Group B (48.8%) (p < 0.05). Clean-contaminated surgeries and comorbidities (DM, HTN) were associated with higher SSI risk. Optimal timing (≤30 min) and IV route were strongly protective. Conclusion: Preoperative IV ceftriaxone given within 30 - 60 minutes before surgical incision is markedly more effective than postoperative therapeutic antibiotics in preventing SSIs. Adherence to prophylaxis timing and antibiotic stewardship is essential to improve surgical outcomes.
Fields of Study & Subjects
Surgical site infection prevention
Urinary Tract Infections Management
Nosocomial Infections in ICU
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 1 January 2026
- Language
- EN